跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 220,738 条关于
“moderate to severe plaque psoriasis”
全部
220,738
临床试验
176,991
药物
2,317
机构
657
资讯
40,773
去年
Bimzelx Shows Remarkable Five-Year Efficacy in Moderate-to-Severe Plaque Psoriasis
9个月前
Takeda's Zasocitinib Achieves Phase 3 Success in Moderate to Severe Plaque Psoriasis
前天
FDA Accepts Takeda's Zasocitinib NDA Under Priority Review for Moderate-to-Severe Plaque Psoriasis
8个月前
Alumis to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis
去年
Deucravacitinib Demonstrates Long-Term Efficacy and Safety in Psoriasis Treatment
3个月前
Akeso's Gumokimab (AK111), an Anti-IL-17 Monoclonal Antibody, Approved by China's NMPA for Moderate-to-Severe Plaque Psoriasis
2年前
FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Plaque Psoriasis
去年
Icotrokinra Shows Promising Phase 3 Results for Moderate to Severe Plaque Psoriasis
去年
Bristol Myers Squibb Announces Positive Data for Sotyktu in Moderate to Severe Psoriasis
去年
FDA Approves Single-Injection 320 mg BIMZELX® for Plaque Psoriasis and Psoriatic Arthritis
第 1 页，共 4078 页
上一页
下一页
